Impact of Co-morbidity on outcomes in Head and Neck cancer patients
Not Applicable
Completed
- Conditions
- Health Condition 1: null- Patient Having Biopsy Proven Squamous cell carcinoma of Head and Neck Cancer.
- Registration Number
- CTRI/2013/11/004154
- Lead Sponsor
- Tata Memorial Centre
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 600
Inclusion Criteria
Patient Having Biopsy Proven Squamous cell carcinoma of Head and Neck Cancer
No history of any prior anti-neoplastic treatment received in last 5 years.
Patients willing for follow-up after treatment
Exclusion Criteria
Patients unreliable for follow up.
Patients not willing to sign informed consent
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To find out prevalence of co-morbidity in patients and to document the change in treatment, based on the severity of co-morbidity in this cohort of patients.Timepoint: To find out prevalence of co-morbidity in patients and to document the change in treatment, based on the severity of co-morbidity in this cohort of patients.
- Secondary Outcome Measures
Name Time Method To assess the impact of co-morbidity on survival (cancer and non cancer related) and the incidence of toxicities and compliance to the planned treatment.Timepoint: Baseline, Follow up- 2 years from end of accrual